Literature DB >> 30957120

Multifunctional two dimensional Bi2Se3 nanodiscs for combined antibacterial and anti-inflammatory therapy for bacterial infections.

Jiang Ouyang1, Mei Wen, Wansong Chen, Yanni Tan, Zhenjun Liu, Qunfang Xu, Ke Zeng, Liu Deng, You-Nian Liu.   

Abstract

A multifunctional platform based on two-dimensional nanomaterials for combined antibacterial and anti-inflammatory therapy is developed. Bi2Se3 nanodiscs selectively eradicate Gram-positive bacteria with a low risk of drug resistance. Moreover, Bi2Se3 nanodiscs with antioxidant activity relieve intracellular oxidative stress of macrophages to suppress inflammation caused by bacterial infections.

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30957120     DOI： 10.1039/c9cc01129c

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN： 1359-7345            Impact factor:   6.222


  4 in total

1.  An NIF-doped ZIF-8 hybrid membrane for continuous antimicrobial treatment.

Authors:  Dan Luo; Cuijuan Wang; Yan Tong; Cheng Liu; Yumei Xiao; Zixin Zhu; DongNing Liu; Yaoyu Wang
Journal:  RSC Adv       Date:  2020-02-19       Impact factor: 4.036

2.  A facile and general method for synthesis of antibiotic-free protein-based hydrogel: Wound dressing for the eradication of drug-resistant bacteria and biofilms.

Authors:  Jiang Ouyang; Qingyue Bu; Na Tao; Mingkai Chen; Haijun Liu; Jun Zhou; Jinggong Liu; Bo Deng; Na Kong; Xingcai Zhang; Tianfeng Chen; Yihai Cao; Wei Tao
Journal:  Bioact Mater       Date:  2022-03-29

3.  Low Dose Soft X-Ray Remotely Triggered Lanthanide Nanovaccine for Deep Tissue CO Gas Release and Activation of Systemic Anti-Tumor Immunoresponse.

Authors:  Youbin Li; Mingyang Jiang; Zhiming Deng; Songjun Zeng; Jianhua Hao
Journal:  Adv Sci (Weinh)       Date:  2021-04-08       Impact factor: 16.806

Review 4.  Two-dimensional nanomaterials beyond graphene for antibacterial applications: current progress and future perspectives.

Authors:  Linqiang Mei; Shuang Zhu; Wenyan Yin; Chunying Chen; Guangjun Nie; Zhanjun Gu; Yuliang Zhao
Journal:  Theranostics       Date:  2020-01-01       Impact factor: 11.556
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.